ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
9,119 announcements with these filters
Q2 FY27 revenue ₹1,746 Cr (+89.9%), PAT before exceptional ₹219.9 Cr (+214.2%), EBITDA margin 17.6%. Net cash ₹1,071 Cr. FY27 revenue guidance raised.
H1 FY27: PAT INR 25,568 Cr (+21.5%), Net VNB INR 6,846 Cr (+34%), VNB margin 22.3% (+4.7ppt). IEV INR 7,97,378 Cr, down YoY from 8,13,230 Cr.
Q2 FY27 record revenue INR 361.1 Cr (+23.9% YoY); EBITDA INR 51.7 Cr at 14.3% margin; PAT flat at INR 26.0 Cr. Pivoting to spooling and integrated piping solutions.
Q2 FY27 operating revenue Rs481cr (+8.0% YoY), PAT Rs116cr (+8.4%), loan book Rs16,425cr (+9.3%), GNPA 2.42%. Sanctions up 12.7% YoY.
Q2 FY27 revenue Rs 2,756 Cr (+11% YoY) and PAT Rs 113 Cr (-5%, 4.1% margin). Order balance Rs 14,250 Cr (+16%), but bookings fell 8%.
Q2 FY27 revenue ₹4,482 Cr (+33%), PAT ₹1,549 Cr (+52%), driven by Subansari commissioning and generation gains. Reported PAT absorbs a ₹231 Cr Tista-4 provision; debt ₹59,000 Cr and receivables ₹4,283 Cr remain soft spots.
Q2 FY27 PAT ₹46 Cr (+31% YoY), NIM 4.24%, GNPA 2.36%. Advances +23% YoY. Management deflected on IRDAI banca fee risk and offered no guidance upgrade.
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
Q2 FY27 revenue +2.4% to ₹2,694mn, PAT flat at ₹562mn, EBITDA margin 39.9%; H1 PAT +8.3%. Q2 hit by Navratri shift; SSSG -5.8%.
Q2 FY27: PAT ₹7.4 Cr (+180.6% YoY), EBITDA ₹13.6 Cr at 25.6% margin; H1 PAT ₹22.5 Cr. Profit rose on deliveries and collections, while H1 bookings fell 35.1%.
Standalone revenue ₹2,019 Cr (+64%) and PAT ₹161 Cr, but group EBITA margin fell to 18.63% from 24.16%. Management raised FY27 growth to ~20% while admitting order inflow is a challenge and working capital stretched to 152 days.
Q2 FY27 consolidated revenue ₹5,921 Mn (+15% YoY), but EBITDA ₹284 Mn (−56%, 4.8% margin) and PAT ₹176 Mn (−58%). Performance Polymers & Chemicals sales +33%; Agri weak.
Q2 revenue rose 23.2% to ₹585 Cr and EBITDA margin reached 12.9% (+90bps), led by festive demand and induction cookware. Exports lagged, and borrowings rose on inventory build-up and China capex.
Q2 FY27 value-added revenue rose 32.2% on volume and content gains; PAT up 15%. Management is upbeat, but commodity cost recovery is unresolved and the export order book has softened sharply.
Q2 FY27 consolidated revenue ₹47.1cr (+50% YoY), EBITDA ₹11.3cr (+65%), PAT ₹6.6cr (+30%). Capacity utilisation 46%. Parenterals facility pending commissioning.
H1FY27 standalone revenue Rs 2,425 Mn (+6.0% YoY), EBITDA margin 10.2%, PAT Rs 172 Mn (-29.3% YoY). CRGO volumes up 28%; FY27 growth guided at 30-35%.
Q2FY27 revenue Rs1,269cr (+18%), EBITDA Rs115cr (+26%), adjusted PAT Rs46cr (+22%). H1 adjusted PAT Rs89cr (+30%). FY27 PAT guidance of Rs200-220cr reiterated.
H1 headline growth is largely timing: carried-over March orders executed in H1, with receivables high and cash conversion weak.
H1 FY27 revenue ₹528.47 Cr (+67.69%), EBITDA ₹42.37 Cr (+99.48%), PAT ₹19.08 Cr (+105%). Margin gains are real, but negative operating cash flow and working-capital strain are played down.
H1 FY27 revenue INR 13.7bn (+14% y-o-y), adj. EBITDA INR 1.8bn (13.1%), PAT INR 0.5bn. Sales fell to INR 38bn; net debt rose to INR 4.5bn. FY27 pre-sales guidance INR 100bn.
Consolidated Q2 revenue rose 31%, but H1 organic growth was only 14%. Pendra Care is loss-making and Italy tenders are delayed. FY27 revenue guidance was reaffirmed and the standalone margin band raised.
Q2 FY27 revenue ₹275.7 Cr (+14.6% YoY), but EBITDA margin fell to 19.4% from 20.3%. Management admits missing its margin target while projecting US-tariff-driven demand upside without order figures.
Record Q2 FY27 revenue of about ₹376 Cr (+28% QoQ), but gross margin fell 4ppt to 49% on West Asia raw-material costs. Management gave no numerical forward guidance; margin recovery depends on price hikes from Q3.
Q2 FY27 standalone revenue ₹895.8 Cr (-6.5% YoY), PAT ₹36.8 Cr flat, EBITDA margin down to 12.2%. Order backlog ₹12,901 Cr.
H1 FY27 revenue ₹95.21 Cr (+27.5% YoY) and PAT ₹12.03 Cr; FY27 revenue outlook raised to ₹202 Cr, but operating cash flow was negative ₹4.7 Cr on receivables stretch.
Consolidated revenue of ₹1,804 Cr (+35% QoQ) and PAT of ₹61 Cr were driven by Punjab's ramp-up. Standalone EBITDA fell 11.7% QoQ as spreads normalised, and the Q1 inventory gain did not repeat.
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
Revenue rose 28% YoY to ₹1,143 Cr, but consolidated EBITDA margin fell to about 36% from 39% on freight, power and staffing costs. Management says gases-segment margin rose to 39%.
Q2 FY27 consolidated revenue Rs 2030 Cr (+2% YoY), EBITDA Rs 67 Cr (-43%, margin 3.3%), PAT loss Rs 376 Cr. Festive shift hit operating leverage.
Q2 FY27 standalone PAT ₹426.66 lakh vs ₹(314.89) lakh loss in Q2 FY26, on total income of ₹28.13 lakh. Company is pivoting to Mumbai redevelopment; no quantified guidance given.